✦ LIBER ✦

Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial

✍ Scribed by Samuel T Henderson; Janet L Vogel; Linda J Barr; Fiona Garvin; Julie J Jones; Lauren C Costantini

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A 22-week, multicenter, randomized, doub

✍ Shahin Akhondzadeh; Mehdi Shafiee Sabet; Mohammad Hossein Harirchian; Mansoreh T 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 161 KB

Cerebrolysin in Alzheimer's disease: a r

✍ M. Panisset; S. Gauthier; H. Moessler; M. Windisch; and The Cerebrolysin Study G 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 103 KB

Cognitive improvement in mild to moderat

✍ Maria De Jesus Moreno Moreno 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 846 KB

A Randomized, Double-blind, Placebo-Cont

📂 Article 📅 2013 🏛 American Medical Association 🌐 English ⚖ 231 KB

Dehydroepiandrosterone treatment of wome

✍ Deh-Ming Chang; Joung-Liang Lan; Hsiao-Yi Lin; Shue-Fen Luo 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB 👁 2 views

The mad-B study: A randomized, double-bl

✍ Eckhart Ruether; Herbert Moessler; Manfred Windisch 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 200 KB